After repeat attempts to convince the U.S.
Healthcare investors can sleep easy tonight with one of 2015’s major unanswered questions now off the table. Celgene Corporation (NASDAQ:CELG) will buy Receptos …
Aduro Bio Tech Inc (NASDAQ:ADRO) begins trading on Wednesday morning at 10:25 ET having completed a $119 million IPO that values the immunotherapy …
Dyax Corp. (NASDAQ:DYAX) saw a gain of over 40% in pre-market trading Wednesday with the release of phase 1b results for DX-2930, an …
Some biopharma business development teams had a sleepless weekend. Four healthcare-related acquisitions were announced in quick succession on Monday morning, totaling about $18 billion …
Medivation Inc (NASDAQ:MDVN) issued a joint statement with Astellas Pharma on Monday announcing detailed results for the use of enzalutamide in castration-resistant prostate …
One of the more anticipated events of early 2015 played out on Friday – detailed results from an early study of Biogen Idec Inc's (NASDAQ:BIIB) experimental …
Even after adding $30 billion in market value over the last four months, shares of Biogen Idec Inc (NASDAQ:BIIB) moved higher on Friday morning with the …
Just a day after Retrophin Inc. (NASDAQ:RTRX) announced a $100 million financing the U.
Xencor, Inc (NASDAQ:XNCR) priced an equity financing on Wednesday morning, selling 7.5 million shares of common stock at $14.
